Registry Study on Primary Ciliary Dyskinesia in Chinese Children

Registry Study on Primary Ciliary Dyskinesia in Chinese children-a Multicenter, Prospective Cohort Study

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02704455

Enrollment

100

Registered

2016-03-10

Start date

2016-05-31

Completion date

2030-07-31

Last updated

2016-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Ciliary Dyskinesia

Keywords

children

Brief summary

This study is a multicenter, prospective cohort study of patients diagnosed with primary ciliary dyskinesia, the clinical information of recruited patients, including clinical manifestations, lung function, chest imaging, quality of life and other indicators, will be followed for 10 years.

Detailed description

All new cases of primary ciliary dyskinesia which was confirmed or diagnosed at each center from the beginning of the study are made the investigation of the clinical manifestations and specific tests by the standard diagnostic process.Then all the patients' following clinical data will be followed for 10 years (once per six month): clinical manifestations, lung function, chest imaging (once per year), quality of life and other indicators.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 18 Years

Healthy volunteers

Inclusion criteria

A included patient must be coincident with all the following items: * Age 0\ 18 years old * Any organ system symptoms consistent with PCD and being conform to the clinical diagnostic standard of Katergener syndrome or being coincident with at least two following specific tests: * Abnormal ciliary beat frequency or movement by the high speed photography microscope * Abnormal ciliary structure through the electronic microscopy * The nasal NO decreased significantly * The target gene mutation found * The clinical diagnostic criteria of the Katergener syndrome: ① bronchial expansion; ② sinusitis or nasal polyps; ③ transposition of viscera and (or) dextrocardia. * If all the typical clinical manifestations but only 1 specific test with positive results, can also be included in the registration of suspected PCD cases * Consent to provide the related clinical specimen to the certain hospital * The guardians of the patients fully understand the purpose of the study, volunteer their children to participate in this study, and sign informed consent.

Exclusion criteria

Subject will be excluded if she or he has one of the following: * It is unable to provide complete medical records or the current condition can not accept the diagnosis process * She or he cannot agree to participate in the study.

Design outcomes

Primary

Measure	Time frame	Description
Change from baseline in lung function on the spirometry	10 years	forced expiratory volume at one second (FEV1) in Liter

Contacts

Primary ContactBaoping Xu, MD, PhD

xubaopingbch@163.com861059616308

Outcome results